abx pt 2 Flashcards
aminoglycosides
used to treat gram-negative aerobic bacilli infections
inhibit protein synthesis
gentamicin, amikacin, neomycin, streptomycin, tobramycin
limited 2/2 side effects
gentamicin (Gentak, Garamycin) action
aminoglycoside prototype
inhibits protein synthesis by directly binding to 30S ribosomal subunit
gentamicin indications
pseudomonas aeruginosa e. coli proteus klebsiella enterobacter penicillin allergies
oral neomycin given as GI surgery prophylaxis
gentamicin pharmacokinetics
PO, IM, topical, opthalmic, intrathecal
poor GI absorption, good IM absorption
does not enter CSF
excreted in urine, breast milk
gentamicin topical cream
do not apply to large area of skin
risk of systemic absorption and toxicity
gentamicin black box warning
can cause fetal harm during pregnancy
potential deafness in fetus
gentamicin contraindications
hypersensitivity
neuromuscular disorders
impaired renal fxn
pregnancy category C
gentamicin side effects
encephalopathy, seizures, ataxia, neuropathy hypotension ototoxicity, tinnitus n/v/d, weight loss nephrotoxicity thrombocytopenia, leukopenia myasthenia-gravis like syndrome rash
aminoglycoside 2 major toxic effects
ototoxicity
nephrotoxicity
gentamicin interactions
NSAIDs, amphoteracin B: risk of nephrotoxicity
cephalosporin, vancomycin, penicillin: enhances effect
neuromuscular blockers: can prolong respiratory paralysis
loop diuretics: ototoxicity
indomethacin: peak/trough levels may rise
heparin is incompatible
do aminoglycosides have adverse CNS effects?
yes but only in PO form
topical, IV, IM do not affect CNS
gentamicin interventions
monitor for tinnitus, hearing loss
evaluate 8th cranial nerve with audiometry
maintain drug levels in therapeutic range (peak/trough)
do not collect blood in heparinized tube
must not mix with other IV medications/infusions
gentamicin pt teaching
report changes in urine
report vision/hearing changes, vertigo, ataxia, seizures, edema
drink fluids
lincosamides
only used when less toxic abx fail
limited to situations w known sensitivity
clindamycin prototype
clindamycin indications
aerobic gram-positive cocci
anaerobic gram-negative and gram-positive organisms
streptococci, pneumococci, staphylococci
clindamycin pharmacokinetics
given IV, IM, PO
metabolized in liver
excreted in bile, urine
clindamycin action
binds to bacterial ribosomes to suppress protein synthesis
clindamycin IV
for infusion: dilute each 300mg in 50 mL solution; give over 30-60 min
incompatible with ampicillin, barbiturates, calcium gluconate, magnesium sulfate, phenytoin
clindamycin PO
do not refrigerate reconstituted oral solution
clindamycin IM
do not exceed 600 mg per injection
clindamycin contraindications
hypersensitivity (may cause severe skin reaction dress syndrome)
pregnancy
asthma
clindamycin black box warning
CDAD
pseudomembranous colitis
clindamycin side effects
thrombophlebitis pseudomembranous colitis rash jaundice thrombocytopenia, leukopenia fatal gasping syndrome in premature infants from benzyl alcohol in drug
clindamycin interactions
neuromuscular blockers: may increase blockade
erythromycin: may block clindamycin action
live virus vaccines: not as effective
cyclosporine: nephrotoxicity